Jeremy Grushcow

Founder — Ph.D. in Molecular Genetics and Cell Biology (University of Chicago, 2000); J.D. with Honors (University of Chicago Law School, 2003). Previously: CBO, Sequence Bio S19 (Raised >$10m; LOIs signed with Sema4, Helix and Biogen); EVP, Strategic Development, Antibe Therapeutics (International partnerships, public company financings and disclosures; preclinical through Phase 1 for a novel pain therapeutic) Best dog dad ever; 7 out of 10 human dad.

Details

linkedin url: https://www.linkedin.com/in/jeremygrushcow/
twitter url: https://twitter.com/crossborderbio

founded → company2

Sequence Bio
Sequence Bio

previously worked at → company1

Antibe Therapeutics